News
More than 40% of U.K. physicians report binge drinking
“We recommend that doctors’ mentors, supervisors, peers, and occupational health support services recognize and act on the prevalence of...
News
Evobrutinib demonstrates efficacy, safety in relapsing MS
PHILADELPHIA – Primary endpoint of reducing enhancing lesions versus placebo was met with evobrutinib.
News
Fingolimod reduced disease activity more than glatiramer acetate in RRMS: ASSESS study results
PHILADELPHIA – Relapse rate and radiographic endpoints significantly improved with the 0.5-mg daily dose of fingolimod, with safety as expected...
News
Ocrelizumab effective, safe in relapsing-remitting MS patients
PHILADELPHIA - A positive risk-to-benefit ratio over nearly 1 year for the anti-CD20 monoclonal antibody.
News
Deutetrabenazine benefit may increase over time in patients with tardive dyskinesia
PHILADELPHIA – Interim results of an open-label study suggest that changes in AIMS score are at least maintained over the course of nearly 3 years...
News
Biomarker-based score predicts poor outcomes after acute ischemic stroke
PHILADELPHIA – A free app and online calculator are available to calculate the four-item ‘CoRisk’ score.
News
Perplexing text messages may be the sole sign of stroke
PHILADELPHIA – The diagnostic importance of “dystextia” is more important now than ever given the ubiquity of smartphones.
News
Rotavirus vaccine had strong protective effect in routine U.K. practice
Vaccine effectiveness was high in children with laboratory-confirmed rotavirus infection, although effects on all-cause gastroenteritis could not...
News
Eculizumab cuts relapse risk in NMO spectrum disorder
PHILADELPHIA – Nearly 98% of patients with this autoimmune inflammatory CNS disorder were relapse-free at 48 weeks in the randomized phase 3...
News
Fournier gangrene cases surge in patients using SGLT2 inhibitors
Serious complications and death are likely if Fournier gangrene is not recognized.
News
Single-center study outlines stroke risk, DOAC type in nonvalvular AFib patients
PHILADELPHIA –Rivaroxaban was more often than other DOACs associated with events in nonvalvular atrial fibrillation patients, based on a small...
News
Immunotherapy induces improvements in PML
PHILADELPHIA – Donor-derived T cells seen as having “potential to be one of the first effective treatments for PML.”
News
Angelman syndrome treatment safe, well-tolerated, and effective in exploratory analyses
PHILADELPHIA – Experimental treatment may benefit adolescents and adults with Angelman syndrome.
News
Direct pharmacy dispensing of naloxone linked to drop in fatal overdoses
But emergency department visits related to opioids increased in new adopters of direct authority laws.
News
Survey: Palliative care blocked by many barriers in end-stage liver disease
Formal palliative care training was lacking among the physicians surveyed.